Compliance
RSSArticles
-
More Attention Now to Workplace Violence; Employers More Receptive
Workplace violence is receiving more attention from hospital and health system leaders. Now may be the time to push for worker safety initiatives that previously could not gain traction.
-
Do Not Forgo HIPAA Requirements in Pandemic Response
The Department of Health and Human Services Office for Civil Rights will disregard some HIPAA violations during the pandemic response. Risk managers should understand which parts of the privacy rule are affected.
-
EMTALA 1135 Waivers Allow Flexibility
The Centers for Medicare & Medicaid Services issued waivers for some Emergency Medical Treatment & Labor Act (EMTALA) requirements, acknowledging certain expectations are not reasonable to achieve during a pandemic. However, EMTALA still applies.
-
Telehealth Rules Eased, but Oversight Still Needed
The federal government acted quickly to make telehealth services more accessible in the COVID-19 pandemic, but risk managers must fully understand the changes to avoid creating liability risks. Some telehealth changes are aimed at making the service reimbursable, and therefore available to more patients. But there also are compliance issues.
-
CMS Issues Stark Waivers, Makes Other Allowances for Pandemic
The Centers for Medicare & Medicaid Services issued waivers and allowances that will affect risk management programs, including 18 blanket waivers of sanctions under the Stark Law.
-
COVID-19 Creates Multiple Risk Exposures as Hospitals Respond
Risk managers should recognize several types of potential liabilities and exposures related to the COVID-19 pandemic response. Some compliance and regulatory burdens have been eased, but risks remain.
-
Global Standards Help Improve Patient Safety and Outcomes
A Louisiana health system is improving safety and patient outcomes by expanding its use of barcodes and other tracking under the commonly used GS1 standards. The effort also is yielding better inventory management. Along the way, the health system developed a GS1 implementation program that other organizations can use.
-
IRBs Can Prepare for Cannabis Research
The cannabis industry is a booming economic force across the nation as states increasingly legalize the sale of medical and/or recreational marijuana. It remains on the national Schedule I list of drugs that are not acceptable for legal sale. But what do healthcare providers really understand about the drug’s safety, risks, and benefits? Not enough, human research protection professionals say.
-
New Working Group to Produce Guidance for Pediatric Gene Therapy
The NYU Grossman School of Medicine’s working group on Pediatric Gene Therapy and Medical Ethics formed in the fall of 2019 to address and propose recommendations to issues involving gene-based therapies in pediatric populations, including research activities.
-
Interactive Online Checklists Help Investigators With Informed Consent
A recent study revealed that an informed consent checklist of basic consent elements guides investigators on how to present key information required by the Common Rule.